title: Effects of a chronic GRF treatment on lambs having low or normal birth weight.
abstract: The effects of a long term treatment with human GRF(1-29)NH2 on plasma growth hormone (GH), somatomedin C (Sm-C), histomorphometric parameters of bone growth and body composition were investigated in normal and low birthweight male lambs. The animals were divided into two groups according to their birthweight: 24 normal birthweight (NBW) lambs weighing more than 4 kg and 22 low birthweight (LBW) lambs weighing less than 2.5 kg at birth. Half of the animals in each group received two daily subcutaneous injections (8 micrograms/kg body weight) of hGRF(1-29) NH2 (GRF) from birth to slaughter at 45 or 90 days of age. The other animals received the solvent only. At the beginning and at the end of the treatment, plasma GH and serum Sm-C concentrations were measured in all groups. After slaughter, a histomorphometric study was performed on undecalcified sections of metacarpal growth plates, and the remaining of the carcass was pulverized to study the chemical body composition. GRF induced GH release in both GRF-treated groups. However, plasma GH reached higher (P less than .001) concentrations and the GRF-induced GH peak lasted longer in LBW than in NBW lambs. At day 45, the GRF treatment increased (P less than .05) serum Sm-C concentrations in LBW. Most of histomorphometric parameters reflecting the metacarpal growth in length, were not statistically modified under GRF treatment. However, the size of degenerative cells was smaller (P less than .05) in LBW treated lambs as compared to controls. Consequently, the cell production in the growth plate was increased (P less than .05) under GRF treatment.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: INRA, Laboratoire de la Production Ovine, Ceyrat, France.
authors.forename: P
authors.initials: P
authors.lastname: Pastoureau
authors.forename: J
authors.initials: J
authors.lastname: Charrier
authors.forename: M M
authors.initials: MM
authors.lastname: Blanchard
authors.forename: G
authors.initials: G
authors.lastname: Boivin
authors.forename: J P
authors.initials: JP
authors.lastname: Dulor
authors.forename: M
authors.initials: M
authors.lastname: Theriez
authors.forename: B
authors.initials: B
authors.lastname: Barenton
mesh_terms: D000818:Animals; D001724:Birth Weight; D001823:Body Composition / Q000187:drug effects*; D013006:Growth Hormone / Q000097:blood* / Q000378:metabolism; D013007:Growth Hormone-Releasing Hormone / Q000494:pharmacology*; D007334:Insulin-Like Growth Factor I / Q000378:metabolism*; D008297:Male; D008663:Metacarpus; D011863:Radioimmunoassay / Q000662:veterinary; D012756:Sheep / Q000097:blood / Q000254:growth & development*; D013002:Somatomedins / Q000378:metabolism*; D013997:Time Factors
chemical_list: D013002:Somatomedins; D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone; D013007:Growth Hormone-Releasing Hormone